BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8752911)

  • 1. CD28 costimulation prevents cell death during primary T cell activation.
    Noel PJ; Boise LH; Green JM; Thompson CB
    J Immunol; 1996 Jul; 157(2):636-42. PubMed ID: 8752911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.
    Radvanyi LG; Shi Y; Vaziri H; Sharma A; Dhala R; Mills GB; Miller RG
    J Immunol; 1996 Mar; 156(5):1788-98. PubMed ID: 8596028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members.
    Kroon HM; Li Q; Teitz-Tennenbaum S; Whitfield JR; Noone AM; Chang AE
    J Immunother; 2007; 30(4):406-16. PubMed ID: 17457215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.
    Tai XG; Toyooka K; Yashiro Y; Abe R; Park CS; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    J Immunol; 1997 Oct; 159(8):3799-807. PubMed ID: 9378967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
    Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
    Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An age-related decrease in rescue from T cell death following costimulation mediated by CD28.
    Engwerda CR; Handwerger BS; Fox BS
    Cell Immunol; 1996 May; 170(1):141-8. PubMed ID: 8660810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 costimulation promotes the production of Th2 cytokines.
    Rulifson IC; Sperling AI; Fields PE; Fitch FW; Bluestone JA
    J Immunol; 1997 Jan; 158(2):658-65. PubMed ID: 8992981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 enhances long-term survival of CD28-deficient T cells.
    Stack RM; Thompson CB; Fitch FW
    J Immunol; 1998 Mar; 160(5):2255-62. PubMed ID: 9498765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
    Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
    Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation.
    Lin RH; Hwang YW; Yang BC; Lin CS
    J Immunol; 1997 Jan; 158(2):598-603. PubMed ID: 8992973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.
    Park CS; Yashiro Y; Tai XG; Toyo-oka K; Hamaoka T; Yagita H; Okumura K; Neben S; Fujiwara H
    J Immunol; 1998 Jun; 160(12):5790-6. PubMed ID: 9637489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
    J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired negative selection in CD28-deficient mice.
    Noel PJ; Alegre ML; Reiner SL; Thompson CB
    Cell Immunol; 1998 Aug; 187(2):131-8. PubMed ID: 9732701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.